{{Cite journal| doi = 10.1186/s13063-025-09248-0| issn = 1745-6215 (Electronic)| volume = 26| issue = 1| pages = 538| last1 = Hosszu-Fellous| first1 = K.| last2 = Poncet| first2 = A.| last3 = Cabecinhas| first3 = A. R. G.| last4 = Schibler| first4 = M.| last5 = Meyer| first5 = B.| last6 = Prendki| first6 = V.| last7 = Huttner| first7 = A.| last8 = Carballo| first8 = S.| last9 = Pouillon| first9 = M.| last10 = Slankamenac| first10 = K.| last11 = Bart| first11 = P. A.| last12 = Bernasconi| first12 = E.| last13 = Manuel| first13 = O.| last14 = Mombelli| first14 = M.| last15 = Mueller| first15 = N. J.| last16 = Kaiser| first16 = L.| last17 = Vetter| first17 = P.| title = Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial)| journal = Trials| date = 2025-11-25| pmid = 41286959}}